Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Black Diamond Therapeutics (BDTX) Shares Outstanding (Diluted Average) (2020 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Shares Outstanding (Diluted Average) for 2 consecutive years, with $36.2 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Shares Outstanding (Diluted Average) rose 13.54% year-over-year to $36.2 million, compared with a TTM value of $36.2 million through Sep 2021, up 13.54%, and an annual FY2020 reading of $32.9 million, changed N/A over the prior year.
  • Shares Outstanding (Diluted Average) was $36.2 million for Q3 2021 at Black Diamond Therapeutics, roughly flat from $36.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $36.2 million in Q2 2021 and bottomed at $23.7 million in Q1 2020.